Foresee Pharmaceuticals Co (ROCO:6576) Operating Margin %: -257.82% (As of Dec. 2025)


ROCO:6576 Foresee Pharmaceuticals Co Ltd ROCO:6576
58 GF Score
Price NT$83.10
GF Value NT$96.69
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Foresee Pharmaceuticals Co Operating Margin %?

Foresee Pharmaceuticals Co ROCO:6576 58 Operating Margin % is -257.82% as of Dec. 2025. GuruFocus rates ROCO:6576 with a GF Score™ of 58/100 and a GF Value™ of NT$96.69 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 956 Drug Manufacturers companies, Foresee Pharmaceuticals Co ranks worse than 93.72% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Foresee Pharmaceuticals Co's Operating Income for the three months ended in Dec. 2025 was NT$-134.6 Mil. Foresee Pharmaceuticals Co's Revenue for the three months ended in Dec. 2025 was NT$52.2 Mil. Therefore, Foresee Pharmaceuticals Co's Operating Margin % for the quarter that ended in Dec. 2025 was -257.82%.

Warning Sign:

Foresee Pharmaceuticals Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -3.4%.

The historical rank and industry rank for Foresee Pharmaceuticals Co's Operating Margin % or its related term are showing as below:

ROCO:6576' s Operating Margin % Range Over the Past 10 Years
Min: -2093.26   Med: -257.9   Max: -155.7
Current: -199.95


ROCO:6576's Operating Margin % is ranked worse than
93.72% of 956 companies
in the Drug Manufacturers industry
Industry Median: 7.58 vs ROCO:6576: -199.95

Foresee Pharmaceuticals Co's 5-Year Average Operating Margin % Growth Rate was -3.40% per year.

Foresee Pharmaceuticals Co's Operating Income for the three months ended in Dec. 2025 was NT$-134.6 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-862.3 Mil.


Foresee Pharmaceuticals Co  (ROCO:6576) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Foresee Pharmaceuticals Co Operating Margin % Related Terms


Foresee Pharmaceuticals Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for Foresee Pharmaceuticals Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foresee Pharmaceuticals Co Operating Margin % Chart

Foresee Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -238.30 -155.70 -516.63 -257.90 -199.95

Foresee Pharmaceuticals Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -347.28 -258.72 -291.91 -73.91 -257.82

ROCO:6576 vs ZTS, UTHR: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Foresee Pharmaceuticals Co Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Foresee Pharmaceuticals Co's Operating Margin % falls into.


ROCO:6576
58GF Score
Foresee Pharmaceuticals Co Ltd ROCO:6576
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Foresee Pharmaceuticals Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Foresee Pharmaceuticals Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-862.316 / 431.274
=-199.95 %

Foresee Pharmaceuticals Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-134.62 / 52.214
=-257.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -257.82% mean?
Foresee Pharmaceuticals Co (ROCO:6576) has a Operating Margin % of -257.82% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Foresee Pharmaceuticals Co and its competitors. According to the industry distribution chart, Foresee Pharmaceuticals Co ranks #896 out of 956 companies in the Drug Manufacturers industry, placing it in the top 93.7%.
Is Foresee Pharmaceuticals Co's Operating Margin % too high?
Foresee Pharmaceuticals Co's current Operating Margin % is -257.82%. Based on the distribution chart, Foresee Pharmaceuticals Co ranks #896 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Foresee Pharmaceuticals Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Foresee Pharmaceuticals Co's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Foresee Pharmaceuticals Co ranks #896 out of 956 companies for Operating Margin %. This places Foresee Pharmaceuticals Co in the lower half of its industry. The industry median Operating Margin % is 7.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Foresee Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Foresee Pharmaceuticals Co's current Operating Margin % is -257.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Foresee Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co (ROCO:6576) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.69, compared to a current price of NT$83.10 — trading 14.1% below its estimated fair value. The current Operating Margin % is -257.82%. Foresee Pharmaceuticals Co's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Foresee Pharmaceuticals Co (ROCO:6576), the current Operating Margin % is -257.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?

Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$83.10 is trading 14.1% below its estimated GF Value™ of NT$96.69. GuruFocus considers Foresee Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for ROCO:6576:

  • Operating Margin %: -257.82%
  • GF Value™: NT$96.69 vs. price of NT$83.10 (14.1% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Foresee Pharmaceuticals Co Business Description

Address No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
58GF Score

Get the complete analysis for ROCO:6576

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.10
Price
NT$96.69
GF Value